Please use this identifier to cite or link to this item:
|Title:||Simplifying skin disease diagnosis with topical nanotechnology||Authors:||Yeo, David Chenloong
|Keywords:||Engineering::Chemical engineering||Issue Date:||2018||Source:||Yeo, D. C., & Xu, C. (2018). Simplifying skin disease diagnosis with topical nanotechnology. SLAS Technology, 23(4), 401-403. doi:10.1177/2472630318775314||Journal:||SLAS Technology||Abstract:||A new study published in the journal Nature Biomedical Engineering1 documents a novel diagnostic technology that exploits topically applied nanotechnology to detect skin tissue biomarkers for diagnosis. This concept is demonstrated by noninvasively imaging connective tissue growth factor (CTGF) mRNA in abnormal scar cells, whole tissue, and animal models. In this commentary, we highlight the main findings and discuss their implications. Successful implementation in the clinic could give rise to self-applied, biopsy-free diagnostic technology and significantly reduce healthcare burden. Crucially, noninvasive visualization of disease biomarkers, mobile device signal acquisition, and Internet-enabled transmission could significantly transform the diagnosis of skin disease and other superficial tissues.||URI:||https://hdl.handle.net/10356/139082||ISSN:||2472-6303||DOI:||10.1177/2472630318775314||Rights:||© 2018 Society for Laboratory Automation and Screening (published by SAGE). All rights reserved.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SCBE Journal Articles|
checked on Sep 3, 2020
Page view(s) 5016
checked on Oct 25, 2020
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.